UBS Group AG 13D/13G Filings for Amneal Pharmaceuticals, Inc. (AMRX)

UBS Group AG 13D and 13G filings for Amneal Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-10
08:59 am
Sale		 2024-12-31 13G Amneal Pharmaceuticals, Inc.
AMRX		 UBS Group AG 0
0.000%		 -21,491,881decrease
(Position Closed)		 Filing
2024-10-30
11:04 am
Purchase		 2024-09-30 13G Amneal Pharmaceuticals, Inc.
AMRX		 UBS Group AG 21,491,881
6.900%		 21,491,881increase
(New Position)		 Filing